Harrington Discovery Institute at University Hospitals announces 2019 grant funding to 10 physician-scientists

Tuesday, December 11, 2018 Hospital News
Email Print This Page Comment bookmark
Font : A-A+

More than 100 drug discovery projects now supported by Harrington Discovery Institute

CLEVELAND, Dec. 10, 2018 /PRNewswire/ -- The Harrington Discovery Institute at University Hospitals in Cleveland,

Ohio, today announced the 2019 Harrington Scholar-Innovator Award recipients. The projects supported by the awards include new therapeutics to treat metabolic disorders, autoimmune disorders and cancer, and new approaches to eradicate parasitic diseases in developing countries.

The Harrington Discovery Institute—part of The Harrington Project for Discovery & Development—is designed to translate science of great promise into therapeutics that can impact human health. Award recipients whose research demonstrates innovation, creativity and the potential to impact standards of care in medicine are selected from institutions across the U.S.  In addition to financial support, the Harrington Discovery Institute provides expertise and oversight in all aspects of drug development.

"Every year we see novel and creative approaches for treating major unmet medical needs. This year was no exception. The 2019 Scholar-Innovator class represents an exciting portfolio of drugs-in-the-making with potential to significantly improve human health. We are honored to support these extraordinary physician-scientists," Jonathan S. Stamler, MD, President of the Harrington Discovery Institute.

The selected scholars have access to several rounds of capital (up to a total of $700,000) through their affiliation with the Harrington Discovery Institute to support the transition of their work into the private sector. Scholars are then free to approach investors of their choice to support the commercialization of their work. They also have facilitated access to BioMotiv, the mission-aligned development company that is part of The Harrington Project.

"Our new class of scholars was selected from a large pool of highly qualified individuals from across the U.S. With this year's class, we have supported over 100 Harrington Scholars," said Mukesh K. Jain, MD, Chief Scientific Officer of the Harrington Discovery Institute.

The 2019 Harrington Scholar-Innovator Award recipients are:

Robert Anderson, MD, PhD University of Oklahoma Health Sciences CenterTreating systemic diseases with very long fatty acids

Rosa Bacchetta, MD Stanford UniversityGenetically modified T cells to treat autoimmune disorders

Gerald Dorn, MD Washington University School of MedicineTargeting mitochondria to treat Charcot Marie Tooth and other neurodegenerative disorders

Joachim Herz, MD University of Texas Southwestern Targeting chronic inflammatory diseases

Paul Hruz, MD, PhD Washington University School of MedicineNovel treatment of non-alcoholic fatty liver disease

Peng Ji, MD, PhD Northwestern University Feinberg School of MedicineIdentification of new therapeutics for blood cancers

V. Vinod Mootha, MD University of Texas SouthwesternPrecision medicine for age-associated vision loss

Dawn Wetzel, MD, PhD University of Texas SouthwesternDeveloping novel, broad-based antiparasitics

T.C. Wu, MD, PhD – The Johns Hopkins School of MedicineAugmenting universal immunity to combat cancer

Ellen Yeh, MD, PhD Stanford UniversityNovel therapeutics to treat malaria

Harrington Discovery Institute The Harrington Discovery Institute at University Hospitals in Cleveland, OH—part of The Harrington Project for Discovery & Development—aims to advance medicine and society by enabling our nation's most inventive scientists to turn their discoveries into medicines that improve human health. The institute was created in 2012 with a $50 million founding gift from the Harrington family and instantiates the commitment they share with University Hospitals to a Vision for a 'Better World'.

The Harrington Project for Discovery & DevelopmentThe Harrington Project for Discovery & Development (The Harrington Project), founded in 2012 by the Harrington Family and University Hospitals of Cleveland, is a $300 million national initiative built to bridge the translational valley of death. It includes the Harrington Discovery Institute and BioMotiv, a for-profit, mission-aligned drug development company that accelerates early discovery into pharma pipelines.

For more information about The Harrington Project and the Harrington Discovery Institute, visit: HarringtonDiscovery.org.

University HospitalsFor information, please go to UHhospitals.org.

 

Cision View original content:http://www.prnewswire.com/news-releases/harrington-discovery-institute-at-university-hospitals-announces-2019-grant-funding-to-10-physician-scientists-300762691.html

SOURCE University Hospitals, Cleveland



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store